openPR Logo
Press release

Inherited Metabolic Disorders Market : Volume Analysis, Segments, Value Share and Key Trends 2017

07-05-2017 01:53 PM CET | Health & Medicine

Press release from: TMR Research

Inherited Metabolic Disorders Market : Volume Analysis, Segments, Value Share and Key Trends 2017

Global Inherited Metabolic Disorders (IMD) Market: Snapshot

Inherited metabolic disorders (IMD), as the name suggests, are genetic conditions resulting in metabolism issues. The root cause behind maximum cases of inherited metabolic disorders (IMD) is a gene mutation that probably happened a lot many generations back. The mutation in the gene is carried through the generations.

Treatment of inherited metabolic disorders (IMD) consists of dietary supplementation, dietary restrictions, drugs that thwart or regulate metabolism, gene therapy, transplantation of the concerned organ, and dialysis in extreme cases. Currently, the dietary supplements account for a leading position in the global inherited metabolic disorders (IMD) treatment market. Drug manufacturers, however, are slated to come up with more condition-specific therapeutics in the near future.

The specificity and high risk affinity of IMD differs from disorder to disorder. Some disorders such as familial cylomicronemia are generally associated closely with Caucasians, while others, namely porphyria is mostly recorded among African Americans. Most of such metabolic disorders are be brought under control with certain changes in the diet and lifestyle of the person. Some inherited metabolic disorders (IMDs) are, however, life threatening. Huntington’s or Zellweger syndrome is to name one such.

Request Sample Copy of the Report @ www.tmrresearch.com/sample/sample?flag=B&rep_id=293

The market for inherited metabolic disorders (IMD) lies mostly with the Caucasian and African American populations of world, especially in North America, Europe, Australia, and Africa, followed by the minority populations from South Asia and East A.

At present, genetic screening using mass spectrometry and DNA testing among all newborns are carried out in almost all of the developed nations of the world and also in developing economies of India, Brazil, and China. This helps uncover inherited metabolic disorders (IMD) at an early stage.

Request TOC of the Report @ www.tmrresearch.com/sample/sample?flag=T&rep_id=293

Global Inherited Metabolic Disorders Market: Overview

Globally, IMD affects nearly one in every 2,500 to 5,000 individuals with nearly 300 to 600 new cases found in the U.K., according to Public Health Genetics U.K. The specificity and high risk affinity of IMD varies from disorder to disorder, with some disorders like familial cylomicronemia being closely associated with Caucasians and others like porphyria being recoded largely among African Americans. These metabolic disorders are often controllable with certain lifestyle and diet changes, including Familial Cylomicronemia and Phenylketonuria. But some IMDs are highly dangerous and may affect the survivability of a person, such as Huntington’s or Zellweger syndrome.

A lot of IMDs arise when the mutated gene responsible is inherited by the natural selection process and a large number of these genes are recessive. This is probably why a large number of these metabolic disorders are rare occurrences, whereas certain other genes are dominant in nature; this makes it difficult for a willing parent to conceive a child as the risk for transferring a gene remains high (e.g. Huntington’s). Familial chylomicronemia occurs when an individual genetically inherits Lipoprotein lipase enzyme mutation. This is a very rare genetic disease at occurrence rate of 1 individual per million with chances of symptoms occurring only in homozygous individuals (receiving mutation genes from both parents) or in other words recessive gene transmission.

Global Inherited Metabolic Disorders Market: Current Market Trends

Nowadays, genetic screening via mass spectrometry and DNA testing of all newborn children are done in nearly all of the developed countries and also some developing countries of the world, including India, China, and Brazil, albeit across a small percentage of the national population. This prepares a parent and the child with the necessary precautions and treatment for increasing the longevity of the concerned newborn. The life expectancy of such a child with all the necessary care and precaution is at par with the average individual.

Read Comprehensive Overview of Report@ www.tmrresearch.com/inherited-metabolic-disorders-market

However among many adult populations and in some children, rare genetic metabolic disorders are abruptly presented and often not accurately diagnosed. In such individuals, abnormal metabolic changes are considered to be a type of genetic mutation in routine diagnosis. Symptoms such as growth failure, precocious puberty and development delay in children below 12, and anemia, neurological disorder, cancer, muscle weakness, rapid hormonal changes, and skin changes in adults, are regarded to probably have a genetic metabolic cause.

Global Inherited Metabolic Disorders Market: Treatment Classifications

The treatment of IMDs is broadly classified into dietary restrictions, dietary supplementation, drugs that inhibit or regulate metabolism, transplantation of the concerned organ, gene therapy, and dialysis in severe cases. In the case of familial cylomicronemia, gene therapy includes Alipogene tiparvovec recombinant gene therapy drug, manufactured by UniQure Inc. This therapy utilizes viruses (adenovirus vector) designed in such a way that upon infection, the gene for producing the lipoprotein lipase is induced into the host cell, thereby producing the enzyme in-vivo. This therapy has shown positive results and is expected to be released into the market soon. For now, the global IMD treatment market lies broadly in the dietary supplements market.

Global Inherited Metabolic Disorders Market: Regional Evaluation

The overall estimated global populations of IMD individuals lie in few millions. The niche category of this segment gives little market for specific condition-related products. However, the implications of therapy are huge as some treatments have the potential to completely eradicate these disorders. Several suitable models have been considered for the treatment of hypercholesterolemia and dyslipidemia, which can in turn alter the outcome of cardiovascular diseases to a bare minimum in the future. For now, the market is open for limitless possibilities.

The market lays primarily with the Caucasian and African American populations of world, especially in North America, Europe, Australia, and Africa, followed by the minority populations from South Asia and East Asia.

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth researh of the market, we try to bring about game-changing success for our clients.

Contact :

Rohit Bhisey
Head - Internet Marketing
Tel: +1-415-520-1050
Email: sales@tmrresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Inherited Metabolic Disorders Market : Volume Analysis, Segments, Value Share and Key Trends 2017 here

News-ID: 610267 • Views: 116

More Releases from TMR Research

Overview On Upcoming Need 2025: Dyslipidemia drugs Market |AstraZeneca, Aegerion …
Global Dyslipidemia Drugs Market: Snapshot Dyslipidemia is a cardiovascular condition comprising of changes in the amount of lipids in the blood. Dyslipidemia can show as either absence of or abundance of lipids in blood; hyperlipidemia, the state of having overabundance lipids in the blood, is probably going to hold the major share in the global dyslipidemia drugs market in the within the forecast period. Various issues related with dietary habits and
Intravenous Iron Drugs Market 2017-2025 | Fresenius Medical Care AG & Co. KGaA, …
Intravenous Iron Drugs Market: Snapshot Iron is one of the most significant minerals required for the correct working of human bodies. Iron insufficiency prompts various medical problems, for example, anemia and could have a grave and direct association with the several of hospitalizations and deaths. The global market for intravenous drugs is foreseen to display a solid CAGR over the report's forecast period attributable to the rising pervasiveness of anemia cases
E-Clinical Solution Software Market Detailed Global Analysis and Forecast 2017-2 …
Global E-Clinical Solution Software Market: Snapshot The current advances in the healthcare industry is witnessing an increasingly connected and technology-advanced operational infrastructure. This has led to it becoming one of the largest producers of sensitive and personal data about the numerous patients it caters to daily. Hospitals, clinics, laboratories, insurance companies and other medical networks are swamped with gargantuan amount of patient information. This has generated an urgent need to create
Nuclear Decommissioning Services Market 2017-2025 | Babcock International Group …
Global Nuclear Decommissioning Services Market: Snapshot The demand in the global market for nuclear decommissioning market is driven by a number of factors including accidents and rising political pressure for pre-closure, stringent regulations since Fukushima accident, public and government support for decommissioning of nuclear reactors, worldwide shut down of older reactors, and increase in the use of renewable energy. On the other hand, stringent regulatory standards, reliability of nuclear power, difficulty

All 26063 Releases


More Releases for IMD

IMD LAUNCHES INTERACTIVE ONLINE CONTEST - GO BEYOND WHAT YOU THINK IS POSSIBLE
Lausanne, Switzerland October 4, 2010 IMD launched today an interactive online contest called Go Beyond What You Think is Possible. Unique to the education sector, the contest gives participants the chance to win an executive education program and become a part of IMDs alumni network. The contest is live at web site. Go Beyond What You Think is Possible is designed around IMDs values: Open, Collaborative and Pioneering. The
IMD 2010 World Competitiveness Yearbook rankings Singapore, Hong Kong and the US …
May 19, 2010 For the first time in decades, Singapore (1) and Hong Kong (2) have topped the USA (3) in IMD’s World Competitiveness Yearbook rankings. They are so close, however, that it would be better to define them as the leading “trio”. In the first 10 places: Australia (5), Taiwan (8) and Malaysia (10) also benefit from strong demand in Asia. Switzerland (4) maintains an excellent position characterized by strong
IMD MBA participant Thom Hermens named a finalist in the Energy for Tomorrow ess …
May 10, 2010 IMD 2010 MBA participant Thom Hermens has been named a top-10 finalist in the Energy for Tomorrow Essay Contest, a project sponsored by Time, Fortune and the Shell Corporation to find “workable and innovative models to help secure a sustainable energy future for the world.” Hermens’ essay is entitled, “Facing the Environmental Challenges of the Future; Committing to a New Framework in Industry to Implement Innovation.” Hermens comes to
Van Oord family establishes new IMD MBA scholarship for candidates from developi …
May 6, 2010 The van Oord Family Association, in charge of the charity activities of the family, and the IMD MBA program announced today the creation of the van Oord Scholarship. According to Jan Kornelis van Oord, Chairman of the Charity Committee of the Family Association, the objective is to provide partial IMD MBA tuition fees for a candidate from a developing country whose advancement / progress has been strongly influenced by
IMD hosts MBA Career Services Counsel European Conference
This week, IMD hosted the MBA Career Services Counsel European Conference – a three-day workshop on best career development and recruiting practices. Some 90 career services professionals from 43 MBA programs (34 European and 9 North American schools) participated, joined by MBA recruiting companies and sponsors. The objectives of the conference were to share best practices in MBA recruiting, promote collaboration among member organizations and develop standard and ethical operating procedures,
IMD and EPFL in Lausanne, Switzerland to host 30th annual Babson College Entrepr …
The 30th annual Babson College Entrepreneurship Research Conference (BCERC), co-sponsored by IMD, a top-ranked business school based in Switzerland, and the École Polytechnique Fédérale de Lausanne (EPFL), is scheduled for June 9 - 12, 2010, in Lausanne, Switzerland. The BCERC, widely considered the premier conference for entrepreneurship research, was established in 1981 to provide a dynamic venue where academics and real-world practitioners link theory and practice, and to encourage and